Characterization of FKGK18 as inhibitor of group VIA Ca2 -independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes (Q28535466)
Jump to navigation
Jump to search
scientific article (publication date: 2013)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterization of FKGK18 as inhibitor of group VIA Ca2 -independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes |
scientific article (publication date: 2013) |
Statements
Characterization of FKGK18 as inhibitor of group VIA Ca2 -independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes (English)
0 references
1 reference
Tomader Ali
1 reference
George Kokotos
1 reference
Victoria Magrioti
1 reference
James A Mobley
1 reference
William Hancock
1 reference
Sasanka Ramanadham
1 reference
2013
0 references
8
0 references
8
0 references
e71748
0 references
20 August 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference